reglab/statecodes huggingface dataset:
New Jersey Administrative Code › Title 13 - LAW AND PUBLIC SAFETY › Chapter 39 - STATE BOARD OF PHARMACY › Subchapter 6 - PHARMACIST-IN-CHARGE; PHARMACY PERSONNEL › Section 13:39-6.2 - Pharmacist-in-charge

Current through Register Vol. 56, No. 14, July 15, 2024
(a) Every pharmacy shall name a pharmacist whose license is in good standing in New Jersey as the pharmacist-in-charge of the pharmacy. No pharmacy shall operate without a pharmacist-in-charge for longer than 30 days.
(b) Whenever the pharmacist-in-charge is absent from the pharmacy for more than 30 days, the pharmacist-in-charge and the permit holder shall notify the Board of the name of the pharmacist who shall act as the interim pharmacist-in-charge.
(c) A pharmacist shall not assume the responsibilities of a pharmacist-in-charge of more than one pharmacy or pharmacy department simultaneously, except as provided in (c)1 below.
1. If an area within a health care facility is permitted as both an institutional pharmacy and a retail pharmacy, the health care facility may employ one individual to act as the pharmacist-in-charge for both the institutional pharmacy and the retail pharmacy.
New Jersey Administrative Code › Title 13 - LAW AND PUBLIC SAFETY › Chapter 39 - STATE BOARD OF PHARMACY › Subchapter 6 - PHARMACIST-IN-CHARGE; PHARMACY PERSONNEL › Section 13:39-6.3 - Identification tag

Current through Register Vol. 56, No. 14, July 15, 2024
All personnel working at any pharmacy practice site, except personnel engaging in the compounding of sterile preparations consistent with the requirements of N.J.A.C. 13:39-11, shall wear an identification tag, which shall include at least the person's first name, first initial of their last name, and job title. The identification tag of any employee in training shall reflect the status of the employee as a trainee.
New Jersey Administrative Code › Title 13 - LAW AND PUBLIC SAFETY › Chapter 39 - STATE BOARD OF PHARMACY › Subchapter 6 - PHARMACIST-IN-CHARGE; PHARMACY PERSONNEL › Section 13:39-6.4 - Meal or restroom breaks

Current through Register Vol. 56, No. 14, July 15, 2024
(a) A sole pharmacist on duty may take restroom breaks and 30-minute meal breaks while working in a pharmacy consistent with the following requirements:
1. The pharmacist shall remain in the pharmacy or, in the case of a pharmacy department, in the pharmacy department building, and shall be accessible for emergencies or for counseling, if requested;
2. The pharmacy shall remain open during the restroom or meal breaks, provided a pharmacy employee remains present in the pharmacy, for patient related services, which include, but are not limited to, the following:
i. The receipt of new written prescriptions; and
ii. The dispensing of prescription medications which have been checked by the pharmacist; and
3. A sign shall be posted in the prescription dispensing area stating "Pharmacist on break, but available for emergencies and counseling."
New Jersey Administrative Code › Title 13 - LAW AND PUBLIC SAFETY › Chapter 39 - STATE BOARD OF PHARMACY › Subchapter 6 - PHARMACIST-IN-CHARGE; PHARMACY PERSONNEL › Section 13:39-6.5 - Prescription handling by pharmacy externs, pharmacy interns, pharmacy technicians, pharmacy technician applicants, or unlicensed or unregistered personnel

Current through Register Vol. 56, No. 14, July 15, 2024
(a) A pharmacy intern, pharmacy extern, pharmacy technician, or pharmacy technician applicant in any pharmacy may perform the component functions of prescription handling described in N.J.A.C. 13:39-4.19, consistent with the requirements of this chapter. All steps performed by a pharmacy technician, pharmacy technician applicant, pharmacy intern, or pharmacy extern shall be documented in the pharmacy audit trail consistent with the requirements of N.J.A.C. 13:39-7.6.
(b) Pharmacy interns and pharmacy externs may assist the pharmacist in performing the following tasks:
1. Retrieval of prescription files, patient files, and profiles and other such records pertaining to the practice of pharmacy;
2. Data entry of prescription medication information, including the original or refill date of the prescription, the number or designation identifying the prescription, the practitioner's information, and the name, strength, and quantity of the prescribed medication;
3. The collection of the following demographic information for the patient profile: the name, address, and telephone number of the patient; the patient's age, date of birth; or age group (infant, child, adult); gender; any allergies and idiosyncrasies of the patient; and any medical conditions that may relate to drug utilization;
4. Transcription of scanned prescription or medication order information into the patient record;
5. Label preparation;
6. The counting, weighing, measuring, pouring, and compounding of prescription medication or stock legend drugs and controlled substances, including the filling of an automated medication system; and
7. Accepting authorization from a patient for a prescription refill, or from a practitioner or his or her agent for a prescription renewal, provided that the prescription remains unchanged.
New Jersey Administrative Code › Title 13 - LAW AND PUBLIC SAFETY › Chapter 39 - STATE BOARD OF PHARMACY › Subchapter 6 - PHARMACIST-IN-CHARGE; PHARMACY PERSONNEL › Section 13:39-6.6 - Pharmacy technician registration and pharmacy technician applicants

Current through Register Vol. 56, No. 14, July 15, 2024
(a) A person wishing to be registered with the Board as a pharmacy technician shall:
1. Be 18 years of age or older;
2. Possess a high school diploma or its equivalent;
3. Submit a certification attesting to the fact that he or she is proficient in written and spoken English;
4. Apply to the Board for registration and submit the application fee set forth in 13:39-1.3;
5. Submit his or her name, address and fingerprints for purposes of a criminal history background check pursuant to 45:1-28 et seq., ( P.L. 2002, c. 104 ) to determine whether criminal history record information exists which may disqualify the applicant from being registered by the Board; and
6. Submit, as part of the application for registration, evidence of good moral character which is an ongoing requirement for registration, and evidence that he or she:
i. Is not presently engaged in drug or alcohol use that is likely to impair the ability to practice as a pharmacy technician with reasonable skill and safety. For purposes of this section, the term "presently" means at the time of application or any time within the previous 365 days;
ii. Has not been convicted of violating any law of this State or any other state of the United States relating to controlled dangerous substances or other habit-forming drugs;
iii. Has not been convicted of violating any law relating to the practice of pharmacy;
iv. Has not been convicted of a crime involving moral turpitude; and
v. Has not had his or her authority to engage in the activity regulated by the Board suspended or revoked as a result of any administrative or disciplinary proceedings in this or any other jurisdiction which determined the applicant to be in violation of any laws, rules or regulations pertaining to the practice of pharmacy, and that the applicant is not currently under suspension or revocation.
New Jersey Administrative Code › Title 13 - LAW AND PUBLIC SAFETY › Chapter 39 - STATE BOARD OF PHARMACY › Subchapter 6 - PHARMACIST-IN-CHARGE; PHARMACY PERSONNEL › Section 13:39-6.7 - Authorization to practice as a pharmacy technician; display of registration

Current through Register Vol. 56, No. 14, July 15, 2024
(a) An applicant for registration as a pharmacy technician who has successfully satisfied all Board requirements for registration and has been approved by the Board to be registered shall, upon payment of the initial registration fee set forth in 13:39-1.3, receive an authorization signed by the Executive Director of the Board granting the applicant the right to practice as a pharmacy technician in the State of New Jersey until such time as an initial registration may be issued. The registrant shall maintain such authorization on his or her person at all times while engaging in the practice of pharmacy as a pharmacy technician until the initial registration is issued.
(b) Upon issuance, the current biennial renewal registration shall be conspicuously displayed in view of the public in the registered pharmacy technician's principal place of employment.
(c) A registered pharmacy technician who is employed by more than one pharmacy in the State shall maintain the wallet-sized registration issued by the Board on his or her person when he or she is working at a location where his or her current biennial renewal registration is not on display.
New Jersey Administrative Code › Title 13 - LAW AND PUBLIC SAFETY › Chapter 39 - STATE BOARD OF PHARMACY › Subchapter 6 - PHARMACIST-IN-CHARGE; PHARMACY PERSONNEL › Section 13:39-6.8 - Replacement of technician registration

Current through Register Vol. 56, No. 14, July 15, 2024
A replacement initial registration or renewal registration shall be issued by the Board upon payment of a fee as prescribed in 13:39-1.3 and upon submission of proof of the applicant's identity and reasonable proof of the loss or destruction of the initial registration or renewal registration, or upon return of the damaged initial registration or renewal registration to the Board.
New Jersey Administrative Code › Title 13 - LAW AND PUBLIC SAFETY › Chapter 39 - STATE BOARD OF PHARMACY › Subchapter 6 - PHARMACIST-IN-CHARGE; PHARMACY PERSONNEL › Section 13:39-6.9 - Technician change of name

Current through Register Vol. 56, No. 14, July 15, 2024
If a registered pharmacy technician legally changes the name under which he or she has been practicing as a pharmacy technician, the pharmacy technician shall notify the Board within 30 days of such change. The registered pharmacy technician shall submit original proof of the change of name or a certified copy of the court order or marriage certificate which shall be retained by the Board. When a replacement registration is issued, the initial registration shall be returned for cancellation and the pharmacy technician shall remit the required fee as prescribed in 13:39-1.3.
New Jersey Administrative Code › Title 13 - LAW AND PUBLIC SAFETY › Chapter 39 - STATE BOARD OF PHARMACY › Subchapter 6 - PHARMACIST-IN-CHARGE; PHARMACY PERSONNEL › Section 13:39-6.10 - Technician change of address of record; service of process

Current through Register Vol. 56, No. 14, July 15, 2024
(a) A registered pharmacy technician shall notify the Board in writing of any change in his or her address of record within 30 days of such change.
(b) Failure to notify the Board of any change in a registered pharmacy technician's address of record pursuant to (a) above may result in disciplinary action in accordance with 45:1-21(h)  and 13:45C-1.3, and the imposition of penalties set forth in 45:1-25.
(c) Service of any administrative complaint or other Board-initiated process at a registered pharmacy technician's address of record shall be deemed adequate notice for the purposes of 1:1-7.1 and the commencement of any disciplinary proceedings.
New Jersey Administrative Code › Title 13 - LAW AND PUBLIC SAFETY › Chapter 39 - STATE BOARD OF PHARMACY › Subchapter 6 - PHARMACIST-IN-CHARGE; PHARMACY PERSONNEL › Section 13:39-6.11 - Verification of technician registration

Current through Register Vol. 56, No. 14, July 15, 2024
A verification that the registration of a pharmacy technician is in good standing shall be supplied by the Board upon written request and upon payment of the fee set forth in 13:39-1.3.
New Jersey Administrative Code › Title 13 - LAW AND PUBLIC SAFETY › Chapter 39 - STATE BOARD OF PHARMACY › Subchapter 6 - PHARMACIST-IN-CHARGE; PHARMACY PERSONNEL › Section 13:39-6.12 - Reproduction of technician registration prohibited

Current through Register Vol. 56, No. 14, July 15, 2024
The initial registration, biennial registration or wallet-sized registration issued by the Board to any pharmacy technician shall not be reprinted, photographed, photostated, duplicated or reproduced by any other means either in whole or in part, except as provided in 13:39-6.8.
New Jersey Administrative Code › Title 13 - LAW AND PUBLIC SAFETY › Chapter 39 - STATE BOARD OF PHARMACY › Subchapter 6 - PHARMACIST-IN-CHARGE; PHARMACY PERSONNEL › Section 13:39-6.13 - Pharmacy technician registration renewal

Current through Register Vol. 56, No. 14, July 15, 2024
(a) The Board shall send a notice of renewal to each pharmacy technician registrant, at least 60 days prior to the expiration of the registration. The notice of renewal shall explain inactive renewal and advise the registrant of the option to renew as inactive. If the notice to renew is not sent 60 days prior to the expiration date, no monetary penalties or fines shall apply to the holder for failure to renew provided that the registration is renewed within 60 days from the date the notice is sent or within 30 days following the date of registration expiration, whichever is later.
(b) A pharmacy technician shall renew his or her registration for a period of two years from the last expiration date. The pharmacy technician shall submit a renewal application to the Board, along with the renewal fee set forth in N.J.A.C. 13:39-1.3, prior to the date of registration expiration.
(c) A pharmacy technician may renew his or her registration by choosing inactive status. A pharmacy technician electing to renew his or her registration as inactive shall not perform the functions of a pharmacy technician, or hold himself or herself out as eligible to perform the functions of a pharmacy technician, in New Jersey until such time as the registration is returned to active status.
(d) If a pharmacy technician does not renew the registration prior to its expiration date, the pharmacy technician may renew the registration within 30 days of its expiration by submitting a renewal application, a renewal fee, and a late fee as set forth in N.J.A.C. 13:39-1.3. During this 30-day period, the registration shall be valid and the pharmacy technician shall not be deemed practicing without a registration.
(e) A pharmacy technician who fails to submit a renewal application within 30 days of registration expiration shall have his or her registration suspended without a hearing.
(f) A pharmacy technician who continues to perform the functions of a pharmacy technician with a suspended registration shall be deemed to be engaging in unauthorized practice and shall be subject to action consistent with N.J.S.A. 45:1-14 et seq., even if no notice of suspension has been provided to the individual.
New Jersey Administrative Code › Title 13 - LAW AND PUBLIC SAFETY › Chapter 39 - STATE BOARD OF PHARMACY › Subchapter 6 - PHARMACIST-IN-CHARGE; PHARMACY PERSONNEL › Section 13:39-6.14 - Pharmacy technician registration reactivation

Current through Register Vol. 56, No. 14, July 15, 2024
(a) A pharmacy technician who holds an inactive registration pursuant to N.J.A.C. 13:39-6.13(c)  may apply to the Board for reactivation of the inactive registration. A pharmacy technician seeking reactivation of an inactive registration shall submit:
1. A renewal application;
2. A certification of employment listing each job held during the period the registration was inactive, which includes the name, address, and telephone number of each employer; and
3. The renewal fee for the biennial period for which reactivation is sought as set forth in N.J.A.C. 13:39-1.3.
i. If the renewal application is sent during the first year of the biennial period, the applicant shall submit the renewal fee as set forth in N.J.A.C. 13:39-1.3.
ii. If the renewal application is sent during the second year of the biennial period, the applicant shall submit one-half of the renewal fee as set forth in N.J.A.C. 13:39-1.3.
New Jersey Administrative Code › Title 13 - LAW AND PUBLIC SAFETY › Chapter 39 - STATE BOARD OF PHARMACY › Subchapter 6 - PHARMACIST-IN-CHARGE; PHARMACY PERSONNEL › Section 13:39-6.14A - Pharmacy technician registration reinstatement from administrative and disciplinary suspensions

Current through Register Vol. 56, No. 14, July 15, 2024
(a) A pharmacy technician who has had his or her registration administratively suspended pursuant to N.J.A.C. 13:39-6.13(e)  may apply to the Board for reinstatement. A pharmacy technician applying for reinstatement shall submit:
1. A reinstatement application;
2. A certification of employment listing each job held during the period of suspended registration, which includes the names, addresses, and telephone number of each employer;
3. The renewal fee for the biennial period for which reinstatement is sought;
4. The past due renewal fee for the biennial period immediately preceding the renewal period for which reinstatement is sought; and
5. The reinstatement fee set forth in N.J.A.C. 13:39-1.3.
New Jersey Administrative Code › Title 13 - LAW AND PUBLIC SAFETY › Chapter 39 - STATE BOARD OF PHARMACY › Subchapter 6 - PHARMACIST-IN-CHARGE; PHARMACY PERSONNEL › Section 13:39-6.15 - Pharmacy technician duties and pharmacist-technician ratios

Current through Register Vol. 56, No. 14, July 15, 2024
(a) Pharmacy technicians and pharmacy technician applicants may assist the pharmacist in performing the following tasks:
1. Retrieval of prescription files, patient files and profiles and other such records pertaining to the practice of pharmacy;
2. Data entry of prescription medication information, including the original or refill date of the prescription, the number or designation identifying the prescription, the practitioner's information, and the name, strength, and quantity of the prescribed medication;
3. The collection of the following demographic information for the patient profile: the name, address, and telephone number of the patient; the patient's age, date of birth; or age group (infant, child, adult); gender; any allergies and idiosyncrasies of the patient; and any medical conditions that may relate to drug utilization;
4. Transcription of scanned prescription or medication order information into the patient record;
5. Label preparation;
6. The counting, weighing, measuring, pouring and compounding of prescription medication or stock legend drugs and controlled substances, including the filling of an automated medication system; and
7. Accepting authorization from a patient for a prescription refill, or from a practitioner or his or her agent for a prescription renewal, provided that the prescription remains unchanged, consistent with (a)7i below:
i. The pharmacy technician or pharmacy technician applicant shall identify himself or herself as a pharmacy technician when accepting authorization from a practitioner or his or her agent. For purposes of this section, "prescription refill" means the dispensing of medications pursuant to a practitioner's authorization provided on the original prescription. For purposes of this section, "prescription renewal" means the dispensing of medications pursuant to a practitioner's authorization to fill an existing prescription that has no refills remaining.
New Jersey Administrative Code › Title 13 - LAW AND PUBLIC SAFETY › Chapter 39 - STATE BOARD OF PHARMACY › Subchapter 7 - DRUG DISPENSING AND PRESCRIPTION RECORDS › Section 13:39-7.1 - Valid prescriptions

Current through Register Vol. 56, No. 14, July 15, 2024
(a) A pharmacist shall only fill a prescription issued by a practitioner licensed to issue prescriptions in New Jersey and practicing in New Jersey if the prescription is on a New Jersey Uniform Prescription Blank pursuant to 45:14-55 and N.J.A.C. 13:45A-27, except as provided in 13:39-7.10 and 7.11.
(b) A pharmacist shall fill a prescription issued by a practitioner authorized to issue prescriptions in another state, territory or possession of the United States, including prescriptions issued at facilities within or outside of New Jersey that are regulated by the United States Department of Veterans Affairs and/or the Department of Defense. Such prescriptions shall be filled pursuant to New Jersey law. Such prescriptions shall not be required to be issued on a New Jersey Uniform Prescription Blank.
(c) Prescriptions, other than those listed in (a) and (b) above, shall not be filled by a pharmacy in New Jersey.
New Jersey Administrative Code › Title 13 - LAW AND PUBLIC SAFETY › Chapter 39 - STATE BOARD OF PHARMACY › Subchapter 7 - DRUG DISPENSING AND PRESCRIPTION RECORDS › Section 13:39-7.2 - Lack of information on original prescription

Current through Register Vol. 56, No. 14, July 15, 2024
(a) If a practitioner fails to include on the original prescription any information that he or she is required to include pursuant to rules governing the practitioner's professional practice, including New Jersey Uniform Prescription Blanks rules set forth at N.J.A.C. 13:45A-27, the pharmacist shall obtain such information.
1. If the practitioner has failed to include directions for use and the practitioner cannot be contacted, the pharmacist shall indicate on the prescription label the words "use as directed" or "as ordered by the physician" or similar words to the same effect.
New Jersey Administrative Code › Title 13 - LAW AND PUBLIC SAFETY › Chapter 39 - STATE BOARD OF PHARMACY › Subchapter 7 - DRUG DISPENSING AND PRESCRIPTION RECORDS › Section 13:39-7.3 - Authorization for renewal of prescriptions; new prescriptions

Current through Register Vol. 56, No. 14, July 15, 2024
(a) A prescription for medication or devices, which pursuant to State or Federal law may be sold, dispensed or furnished only upon prescription, shall not be renewed without specific authorization of the practitioner or the practitioner's authorized agent, and the prescription may not be filled or refilled after one year from the date the original prescription was issued. A pharmacist obtaining authorization from a practitioner's authorized agent shall document the name and title of the agent.
1. Prescriptions marked "PRN" or other letters or words meaning refill as needed shall not be renewed beyond one year past the date the original prescription was issued.
New Jersey Administrative Code › Title 13 - LAW AND PUBLIC SAFETY › Chapter 39 - STATE BOARD OF PHARMACY › Subchapter 7 - DRUG DISPENSING AND PRESCRIPTION RECORDS › Section 13:39-7.4 - Emergency dispensing

Current through Register Vol. 56, No. 14, July 15, 2024
(a) Except as provided in (b) below, in the absence of a current, valid prescription, a pharmacist may dispense an emergency supply (no more than a 72-hour quantity) of a chronic maintenance drug or device if, in his or her professional judgment, refusal would endanger the health or welfare of the patient, provided the following conditions are satisfied:
1. The pharmacist first ascertains to the best of his or her ability, by direct communication with the patient or caregiver, that such a medication or device was prescribed for that patient by order of a practitioner. The pharmacist shall require the patient or caregiver to provide suitable identification. Such communication shall be documented in the patient profile record system maintained pursuant to 13:39-7.19 or in the pharmacy's other manual or electronic files; and
2. The pharmacist documents the dispensing of the emergency supply in the prescription record system.
New Jersey Administrative Code › Title 13 - LAW AND PUBLIC SAFETY › Chapter 39 - STATE BOARD OF PHARMACY › Subchapter 7 - DRUG DISPENSING AND PRESCRIPTION RECORDS › Section 13:39-7.5 - Approval of FDA necessary

Current through Register Vol. 56, No. 14, July 15, 2024
(a) No drug or medicine other than a compounded prescription order, consistent with (c) below, shall be sold or dispensed in any pharmacy within the State of New Jersey until such drug or medicine has received New Drug Application (NDA), Abbreviated New Drug Application (ANDA), Investigational New Drug Application (INDA) or other Federal Food and Drug Administration (FDA) approval, where required.
(b) The storage, labeling, and dispensing of all Investigational New Drugs shall be a pharmaceutical service provided in cooperation with, and in support of the principal investigator. Under these parameters the dispensing of such drugs shall not be construed to be a violation of (a) above. A pharmacy participating in experimental research shall comply with Federal Department of Health and Human Services regulations set forth at 45 CFR Part 46, Protection of Human Subjects of Research, incorporated by reference herein, as amended and supplemented and with the Rowan University Guidance on Human Subjects Research, which is incorporated herein by reference, as amended and supplemented, and which is available at
http://www.rowan.edu/som/hsp/guidance/index.html
.
(c) No pharmacy or pharmacist shall compound products prohibited by the FDA or use ingredients that are restricted by the FDA.
New Jersey Administrative Code › Title 13 - LAW AND PUBLIC SAFETY › Chapter 39 - STATE BOARD OF PHARMACY › Subchapter 7 - DRUG DISPENSING AND PRESCRIPTION RECORDS › Section 13:39-7.7 - Copies of prescriptions and/or patient profile

Current through Register Vol. 56, No. 14, July 15, 2024
(a) A pharmacy shall immediately comply with the patient's request for copies of prescriptions and/or patient profile. Copies of prescriptions issued directly to the patient shall state in letters at least equal in size to those describing the medication dispensed, the underlined statement: "COPY--FOR INFORMATION ONLY." For purposes of this section, for requests for prescriptions that are one year or less from the original date of filling, "immediately" shall not exceed 24 hours. For all other prescriptions, "immediately" shall not exceed 72 hours.
(b) Presentation of a prescription marked "COPY--FOR INFORMATION ONLY" or a labeled prescription container shall be for information purposes only and shall have no legal status as a valid prescription order. The pharmacist in receipt of such copy or labeled prescription container shall contact the prescribing practitioner for a new prescription or the last dispensing pharmacy to transfer the prescription pursuant to 13:39-7.8.
New Jersey Administrative Code › Title 13 - LAW AND PUBLIC SAFETY › Chapter 39 - STATE BOARD OF PHARMACY › Subchapter 7 - DRUG DISPENSING AND PRESCRIPTION RECORDS › Section 13:39-7.8 - Transfer of prescriptions between pharmacies

Current through Register Vol. 56, No. 14, July 15, 2024
(a) When a patient, the patient's caregiver, or a pharmacy acting on behalf of a patient or caregiver requests the transfer of a valid prescription between pharmacies, a pharmacy, the registered pharmacist-in-charge, and the pharmacist who receives the request for transfer shall immediately comply with the patient's request. For purposes of this section, "immediately" shall not exceed four hours.
(b) Except as provided in (c) and (d) below, a prescription may be transferred between pharmacies, consistent with this section, for one year from the date the prescription was written, provided refills of the prescription are available.
(c) A prescription for a Schedule II controlled substances may not be transferred.
(d) A prescription for a Schedule III, IV, or V controlled substance may be transferred between pharmacies pursuant to N.J.A.C. 13:45H-7.18. A prescription for a Schedule III, IV, or V controlled substance that has been transferred shall not be transferred a second time. This prohibition shall not apply to the transfer of such prescriptions between pharmacies engaged in central prescription handling pursuant to N.J.A.C. 13:39-4.18(e)  and to pharmacies that share a real-time, online database consistent with the requirements of 21 CFR 1306.25.
(e) A prescription may be transferred between pharmacies for the purpose of refill dispensing by telephone, or by facsimile or electronic means as provided in 13:39-7.10 and 7.11, provided that:
1. The sending pharmacy invalidates the prescription on file as of the date the prescription is transferred and records on the back of the invalidated prescription order or in the electronic system the following:
i. That the prescription has been transferred and the date of transfer;
ii. The name and address or store identifier of the pharmacy to which the prescription was transferred;
iii. The name or personal identifier of the pharmacist, intern or extern to whom the prescription was transferred; and
iv. The initials or personal identifier of the pharmacist, intern, or extern issuing the transferred prescription order;
New Jersey Administrative Code › Title 13 - LAW AND PUBLIC SAFETY › Chapter 39 - STATE BOARD OF PHARMACY › Subchapter 7 - DRUG DISPENSING AND PRESCRIPTION RECORDS › Section 13:39-7.9 - Filing and storage of controlled substance prescriptions

Current through Register Vol. 56, No. 14, July 15, 2024
(a) Prescriptions for all controlled substances listed in Schedule II shall be maintained in a separate prescription file.
(b) Prescriptions for all controlled substances listed in Schedules III, IV and V shall be maintained in a separate prescription file for such controlled substances only or in such form that they are readily retrievable from other prescription records of the pharmacy. Prescriptions will be deemed readily retrievable if, at the time they are initially filed, the face of the prescription is stamped in red ink in the lower right corner with the letter "C" no less than one-inch high and filed either in the prescription file for controlled substances listed in Schedule II or in the prescription file for non-controlled substances. If a pharmacy employs an electronic recordkeeping system for prescriptions that permits identification by prescription number and retrieval of original documents by the practitioner's name, patient's name, drug dispensed and date filled, then the requirement to mark the hard copy prescription with a red "C" shall be waived.
New Jersey Administrative Code › Title 13 - LAW AND PUBLIC SAFETY › Chapter 39 - STATE BOARD OF PHARMACY › Subchapter 7 - DRUG DISPENSING AND PRESCRIPTION RECORDS › Section 13:39-7.10 - Prescriptions transmitted by facsimile

Current through Register Vol. 56, No. 14, July 15, 2024
(a) A pharmacist may accept for dispensing a facsimile prescription, consistent with the requirements of this section. For purposes of this section, "facsimile prescription" means a prescription which is transmitted by a device which sends an exact image to the receiver.
(b) A pharmacist shall not fill a facsimile prescription transmitted by anyone other than a practitioner authorized to prescribe medications pursuant to 45:14-40, or the prescribing practitioner's authorized agent.
(c) The facsimile machine used to receive prescriptions shall be located within the pharmacy prescription area.
(d) A facsimile prescription shall contain all information required to be included on a written prescription pursuant to New Jersey State Board of Medical Examiners rule 13:35-7.2(d), except that an NJPB shall not be required for the prescription.
(e) The facsimile transmission of the prescription shall contain the following:
1. The identification number of the facsimile machine which is used to transmit the prescription;
2. The date and time of the prescription transmission;
3. The name, address, telephone number and facsimile number of the pharmacy; and
4. If an authorized agent transmits the facsimile prescription, the full name and title of the transmitting agent.
New Jersey Administrative Code › Title 13 - LAW AND PUBLIC SAFETY › Chapter 39 - STATE BOARD OF PHARMACY › Subchapter 7 - DRUG DISPENSING AND PRESCRIPTION RECORDS › Section 13:39-7.12 - Labeling

Current through Register Vol. 56, No. 14, July 15, 2024
(a) The dispensed container for any product shall bear a permanently affixed label with at least the following information:
1. The pharmacy name and address;
2. The pharmacy telephone number;
3. The brand name, or if a generic, the brand name, if still available in the marketplace, and the name of the generic in the following form, with the generic name and brand name inserted as appropriate:
" ----------- Generic for ------------- "
If the brand name is not still available in the marketplace, the generic name.
4. The strength of medication, where applicable;
5. The quantity dispensed;
6. The date upon which prescription medication is dispensed;
7. A CDS cautionary label, where applicable;
8. The patient name;
9. The practitioner's name;
10. The prescription number;
11. Directions for use;
12. The phrase "use by" followed by the product's use by date, if dispensed in any packaging other than the manufacturer's original packaging.
i. For purposes of this paragraph, "use by date" means the earlier of one year from the date of dispensing or the expiration date on the manufacturer's container; and
13. For substituted biological products, the information required in N.J.A.C. 13:39-7.23(d).
New Jersey Administrative Code › Title 13 - LAW AND PUBLIC SAFETY › Chapter 39 - STATE BOARD OF PHARMACY › Subchapter 7 - DRUG DISPENSING AND PRESCRIPTION RECORDS › Section 13:39-7.13 - Professional judgment in dispensing drugs

Current through Register Vol. 56, No. 14, July 15, 2024
The pharmacist shall have the right to refuse to fill a prescription if, in his or her professional judgment, the prescription is outside the scope of practice of the practitioner; or if the pharmacist has sufficient reason to question the validity of the prescription; or to protect the health and welfare of the patient.
New Jersey Administrative Code › Title 13 - LAW AND PUBLIC SAFETY › Chapter 39 - STATE BOARD OF PHARMACY › Subchapter 7 - DRUG DISPENSING AND PRESCRIPTION RECORDS › Section 13:39-7.14 - Advertising and sale of prescription drugs

Current through Register Vol. 56, No. 14, July 15, 2024
(a) "Advertisement" means any attempt directly or indirectly by publication, dissemination, or circulation in print or electronic media which directly or indirectly induces or attempts to induce any person or entity to purchase or enter into an agreement to purchase services or goods from a Board licensee.
(b) Price quotations for prescription drugs appearing in any advertisement shall stipulate the strength and quantity required to be purchased for the offered cost. Price quotations shall include the usual and customary prescription cost. All services including, but not limited to, delivery charges rendered by the pharmacy which will add additional costs to the price quoted, must be set forth in the advertisement.
(c) Any reference in any form of advertisement to the quality of a drug or its beneficial use is prohibited.
(d) Price quotations for drugs appearing in any advertisement shall stipulate the effective period of price quotation.
(e) Upon request by any consumer, the pharmacist shall give usual and customary price information for a non-third party paying customer over the telephone and shall stipulate the effective period of the price quotation.
(f) All advertisements shall be predominantly informational and shall not be misleading, confusing or false. Any advertisement demeaning the quality of professional services rendered by another licensee or permittee shall be prohibited.
New Jersey Administrative Code › Title 13 - LAW AND PUBLIC SAFETY › Chapter 39 - STATE BOARD OF PHARMACY › Subchapter 7 - DRUG DISPENSING AND PRESCRIPTION RECORDS › Section 13:39-7.15 - Restriction on sale of Schedule V over-the-counter controlled substances

Current through Register Vol. 56, No. 14, July 15, 2024
(a) It shall be considered unprofessional conduct for a pharmacist to dispense a Schedule V over-the-counter controlled substance when:
1. The pharmacist, in his or her professional judgment, knows or reasonably should know that the requested substance will be used for unauthorized or illicit consumption or distribution; or
2. The pharmacist, in his or her professional judgment, knows or reasonably should know that the person requesting the substance previously used it for unauthorized or illicit consumption or distribution.
New Jersey Administrative Code › Title 13 - LAW AND PUBLIC SAFETY › Chapter 39 - STATE BOARD OF PHARMACY › Subchapter 7 - DRUG DISPENSING AND PRESCRIPTION RECORDS › Section 13:39-7.16 - Return of prescription medication

Current through Register Vol. 56, No. 14, July 15, 2024
(a) Prescription medication correctly dispensed to a patient may be accepted for return by the pharmacist but shall not be placed in stock for reuse or resale, except as provided in 13:39-9.18(a)2.
(b) Prescription medication incorrectly dispensed to a patient shall be accepted for return by the pharmacist and shall not be placed back in stock for reuse or resale.
(c) For purposes of this subsection, a prescription medication shall be considered to be abandoned when a prescription is prepared and made available for dispensing by the pharmacy but is not dispensed to the patient for whom it was prepared within two weeks. Prescription medication that has been prepared for a patient and that is abandoned by a patient, or that has not been dispensed by a long-term care pharmacy to a patient in a long-term care facility, may be placed back in stock for reuse or resale provided that:
1. In the professional judgment of the pharmacist, the prescription medication is eligible for re-dispensing. Eligible medications are those medications that are able to be consumed by a patient within the original time frame established for the medication's stability and expiration, were maintained under proper storage conditions to ensure their integrity, and have remained under the exclusive control and custody of the pharmacy or the patient's long-term care facility, as applicable, at all times. Products that have a limited shelf life and/or that have not been stored consistent with manufacturers' storage requirements may not be re-dispensed;
2. The prescription medication shall not be placed in manufacturers' stock containers of different lot numbers and/or with different expiration dates;
3. Manufacturers' stock containers shall not be over-filled;
4. In those circumstances in which prescription medications cannot be properly returned to the original manufacturers' stock containers, the medication shall be held in the pharmacy in the labeled container in which it has been repackaged. Prior to redispensing, such medications shall be placed in a new container with a new label or the original label shall be removed and the container shall be relabeled;
5. If the manufacturer or the FDA orders a recall of a drug product, the pharmacist shall assume products held in labeled containers without lot numbers are included in the recall and proceed accordingly; and
6. Medications held for re-dispensing shall be used as soon as possible. Such medications, lacking original lot numbers and expiration dates, shall not be dispensed to patients later than one year from the date the medications were originally prepared for dispensing. Re-dispensed medications shall be marked with the same use by date as the medication which was originally prepared for dispensing.
New Jersey Administrative Code › Title 13 - LAW AND PUBLIC SAFETY › Chapter 39 - STATE BOARD OF PHARMACY › Subchapter 7 - DRUG DISPENSING AND PRESCRIPTION RECORDS › Section 13:39-7.17 - Disposal of unwanted drugs

Current through Register Vol. 56, No. 14, July 15, 2024
Unwanted drugs shall be disposed of in a manner that does not cause them to become a health hazard, and in accordance with all local, State, and Federal codes.
New Jersey Administrative Code › Title 13 - LAW AND PUBLIC SAFETY › Chapter 39 - STATE BOARD OF PHARMACY › Subchapter 7 - DRUG DISPENSING AND PRESCRIPTION RECORDS › Section 13:39-7.18 - Outdated drugs or drugs marked "sample"

Current through Register Vol. 56, No. 14, July 15, 2024
No outdated, misbranded, deteriorated, improperly stored or adulterated drugs, or any drugs marked "sample" or with any like designation or meaning shall be dispensed or placed or maintained in active stock for use or sale.
New Jersey Administrative Code › Title 13 - LAW AND PUBLIC SAFETY › Chapter 39 - STATE BOARD OF PHARMACY › Subchapter 7 - DRUG DISPENSING AND PRESCRIPTION RECORDS › Section 13:39-7.19 - Patient profile record system

Current through Register Vol. 56, No. 14, July 15, 2024
(a) An electronic patient profile system shall be maintained by all pharmacies for persons for whom prescriptions are dispensed. The Patient Profile Record System (PPRS) shall be devised, so as to enable the immediate retrieval of current clinical information necessary to enable the dispensing pharmacist to identify previously dispensed medication and patient specific information at the time a prescription is presented for dispensing.
(b) The following information shall be recorded in the PPRS:
1. The family name and the first name of the person for whom the medication is intended (the patient);
2. The address and telephone number of the patient;
3. Indication of the patient's age, birth date or age group (infant, child, adult) and gender;
4. The original or refill date the medication is dispensed;
5. The number or designation identifying the prescription;
6. The practitioner's name;
7. The name, strength and quantity of the drug dispensed;
8. Pharmacist's comments relevant to the patient's drug therapy; and
9. Any allergies and idiosyncrasies of the patient and any medical conditions that may relate to drug utilization, as communicated by the patient or the patient's representative.
i. If there are no patient allergies, idiosyncrasies or medical conditions that may relate to drug utilization, such information shall be documented in the patient profile record system.
New Jersey Administrative Code › Title 13 - LAW AND PUBLIC SAFETY › Chapter 39 - STATE BOARD OF PHARMACY › Subchapter 7 - DRUG DISPENSING AND PRESCRIPTION RECORDS › Section 13:39-7.20 - Drug utilization review

Current through Register Vol. 56, No. 14, July 15, 2024
(a) Upon receipt of a new or refill prescription, a pharmacist shall examine the patient's profile record before dispensing the medication, to determine the possibility of a potentially significant drug interaction, reaction or misutilization of the prescription. Upon determining a potentially significant drug interaction, reaction or misutilization, the pharmacist shall take the appropriate action to avoid or minimize the problem, which shall, if necessary, include consultation with the patient and/or the practitioner.
(b) Upon receipt of a refill prescription, a pharmacist shall determine if a substantial time, as is appropriate for that drug in the pharmacist's professional judgment, has elapsed from the last filling. When necessary, the pharmacist shall consult with the practitioner and/or the patient to ensure that continued use of the medication is appropriate.
(c) When patient profile records indicate sporadic, erratic or irrational use of medication by a patient, the pharmacist shall consult with the patient and/or the practitioner to determine if continued use of the medication is appropriate.
New Jersey Administrative Code › Title 13 - LAW AND PUBLIC SAFETY › Chapter 39 - STATE BOARD OF PHARMACY › Subchapter 7 - DRUG DISPENSING AND PRESCRIPTION RECORDS › Section 13:39-7.21 - Patient counseling

Current through Register Vol. 56, No. 14, July 15, 2024
(a) Except as provided in (a)5 below, before dispensing a new medication, a pharmacist shall make reasonable efforts to counsel the patient or the patient's caregiver. Counseling may include the following:
1. The name and description of the medication;
2. The dosage form, dosage, route of administration, and duration of drug therapy;
3. Special directions and precautions for preparation, administration and use by the patient;
4. Common adverse or severe side effects or interactions and contraindications that may be encountered, including how to avoid such side effects, interactions and contraindications, and the action required if they occur;
5. Techniques for self-monitoring drug therapy;
6. Proper storage;
7. Prescription refill information; and
8. Action to be taken in the event of a missed dose.
New Jersey Administrative Code › Title 13 - LAW AND PUBLIC SAFETY › Chapter 39 - STATE BOARD OF PHARMACY › Subchapter 7 - DRUG DISPENSING AND PRESCRIPTION RECORDS › Section 13:39-7.22 - Accurate processing and dispensing

Current through Register Vol. 56, No. 14, July 15, 2024
A pharmacist shall be responsible for the processing, accuracy, appropriateness, and dispensing of the filled prescription.
New Jersey Administrative Code › Title 13 - LAW AND PUBLIC SAFETY › Chapter 39 - STATE BOARD OF PHARMACY › Subchapter 7 - DRUG DISPENSING AND PRESCRIPTION RECORDS › Section 13:39-7.23 - Biological products

Current through Register Vol. 56, No. 14, July 15, 2024
(a) A pharmacist may substitute a biological product for a prescribed biological product, provided that the following conditions are met:
1. The authorized prescriber has not indicated that there shall be no substitution as set forth in N.J.S.A. 24:6E-7; and
2. The biological product to be substituted has been determined by the Federal Food and Drug Administration (FDA) to be:
i. Interchangeable with the prescribed biological product; or
ii. Therapeutically equivalent to the prescribed biological product.
New Jersey Administrative Code › Title 13 - LAW AND PUBLIC SAFETY › Chapter 39 - STATE BOARD OF PHARMACY › Subchapter 9 - PHARMACEUTICAL SERVICES FOR HEALTH CARE FACILITIES › Section 13:39-9.1 - Purpose and scope

Current through Register Vol. 56, No. 14, July 15, 2024
(a) The rules in this subchapter shall apply to all retail pharmacies which contract to provide pharmaceutical services for healthcare facilities and to all institutional pharmacies which provide pharmaceutical services for their own health care system.
(b) An institutional pharmacy filling prescriptions for outpatient use shall comply with all retail pharmacy requirements of this chapter.
New Jersey Administrative Code › Title 13 - LAW AND PUBLIC SAFETY › Chapter 39 - STATE BOARD OF PHARMACY › Subchapter 9 - PHARMACEUTICAL SERVICES FOR HEALTH CARE FACILITIES › Section 13:39-9.3 - Licensure of institutional pharmacies

Current through Register Vol. 56, No. 14, July 15, 2024
(a) Any institutional pharmacy as defined under 13:39-9.2 shall be registered with and possess an institutional permit issued by the Board. The permit shall be conspicuously displayed in the facility's pharmacy. The institutional pharmacy is subject to and shall be conducted in accordance with all existing State and Federal rules and regulations.
(b) An institutional pharmacy that is part of a health care system may fill medication orders for health care facilities that are part of the health care system and that provide pharmaceutical services directly to the patients of the health care system.
New Jersey Administrative Code › Title 13 - LAW AND PUBLIC SAFETY › Chapter 39 - STATE BOARD OF PHARMACY › Subchapter 9 - PHARMACEUTICAL SERVICES FOR HEALTH CARE FACILITIES › Section 13:39-9.4 - Contract pharmaceutical services; institutional permit required

Current through Register Vol. 56, No. 14, July 15, 2024
An institutional permit is required for any area within an institution serviced by an outside vendor that performs on-site pharmaceutical services as defined in 13:39-1.2.
New Jersey Administrative Code › Title 13 - LAW AND PUBLIC SAFETY › Chapter 39 - STATE BOARD OF PHARMACY › Subchapter 9 - PHARMACEUTICAL SERVICES FOR HEALTH CARE FACILITIES › Section 13:39-9.5 - Advisory committees

Current through Register Vol. 56, No. 14, July 15, 2024
The pharmacist-in-charge, or designee, shall be an actively participating member on any committees of the facility that may be concerned with drugs and their utilization.